TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biomedica Norden AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4,645
|
4,576
|
4,335 |
| Financial expenses |
96
|
169
|
111 |
| Earnings before taxes |
12
|
-50
|
-57 |
| EBITDA |
529
|
625
|
527 |
| Total assets |
2,418
|
2,382
|
2,606 |
| Current assets |
1,444
|
907
|
758 |
| Current liabilities |
573
|
404
|
714 |
| Equity capital |
365
|
347
|
370 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
1
|
1
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
15.1%
|
14.6%
|
14.2% |
| Turnover per employee |
4,645
|
4,576
|
2,168 |
| Profit as a percentage of turnover |
0.3%
|
-1.1%
|
-1.3% |
| Return on assets (ROA) |
4.5%
|
5.0%
|
2.1% |
| Current ratio |
252.0%
|
224.5%
|
106.2% |
| Return on equity (ROE) |
3.3%
|
-14.4%
|
-15.4% |
| Change turnover |
-13
|
-67
|
12 |
| Change turnover % |
0%
|
-1%
|
0% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-50%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.